tetano
Editor, Senior Moderator
Semin Immunol. 2018 Dec;40:83-94. doi: 10.1016/j.smim.2018.10.010.
[h=1]Vaccination in the elderly: The challenge of immune changes with aging.[/h] Ciabattini A[SUP]1[/SUP], Nardini C[SUP]2[/SUP], Santoro F[SUP]1[/SUP], Garagnani P[SUP]3[/SUP], Franceschi C[SUP]4[/SUP], Medaglini D[SUP]5[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] The unprecedented increase of life expectancy challenges society to protect the elderly from morbidity and mortality making vaccination a crucial mean to safeguard this population. Indeed, infectious diseases, such as influenza and pneumonia, are among the top killers of elderly people in the world. Elderly individuals are more prone to severe infections and less responsive to vaccination prevention, due to immunosenescence combined with the progressive increase of a proinflammatory status characteristic of the aging process (inflammaging). These factors are responsible for most age-related diseases and correlate with poor response to vaccination. Therefore, it is of utmost interest to deepen the knowledge regarding the role of inflammaging in vaccination responsiveness to support the development of effective vaccination strategies designed for elderly. In this review we analyse the impact of age-associated factors such as inflammaging, immunosenescence and immunobiography on immune response to vaccination in the elderly, and we consider systems biology approaches as a mean for integrating a multitude of data in order to rationally design vaccination approaches specifically tailored for the elderly.
[h=4]KEYWORDS:[/h] Elderly vaccination; Immunobiography; Immunosenescence; Inflammaging; Systems biology; Vaccine adjuvants
PMID: 30501873 DOI: 10.1016/j.smim.2018.10.010
[h=1]Vaccination in the elderly: The challenge of immune changes with aging.[/h] Ciabattini A[SUP]1[/SUP], Nardini C[SUP]2[/SUP], Santoro F[SUP]1[/SUP], Garagnani P[SUP]3[/SUP], Franceschi C[SUP]4[/SUP], Medaglini D[SUP]5[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] The unprecedented increase of life expectancy challenges society to protect the elderly from morbidity and mortality making vaccination a crucial mean to safeguard this population. Indeed, infectious diseases, such as influenza and pneumonia, are among the top killers of elderly people in the world. Elderly individuals are more prone to severe infections and less responsive to vaccination prevention, due to immunosenescence combined with the progressive increase of a proinflammatory status characteristic of the aging process (inflammaging). These factors are responsible for most age-related diseases and correlate with poor response to vaccination. Therefore, it is of utmost interest to deepen the knowledge regarding the role of inflammaging in vaccination responsiveness to support the development of effective vaccination strategies designed for elderly. In this review we analyse the impact of age-associated factors such as inflammaging, immunosenescence and immunobiography on immune response to vaccination in the elderly, and we consider systems biology approaches as a mean for integrating a multitude of data in order to rationally design vaccination approaches specifically tailored for the elderly.
[h=4]KEYWORDS:[/h] Elderly vaccination; Immunobiography; Immunosenescence; Inflammaging; Systems biology; Vaccine adjuvants
PMID: 30501873 DOI: 10.1016/j.smim.2018.10.010